Highmark Health, Allegheny Health Network and Torax Medical Partner to Explore Cost-Effectiveness of New Procedure to Treat Gastro-esophageal Reflux Disease (GERD)
The VITAL innovation program is a formal, rapid and competitive review and funding process open to innovators who wish to test new ideas to improve the quality and affordability of care.
"This collaboration aligns with our mission to be a value-based health provider," said
"Torax Medical and physician thought leaders have collaborated for over a decade building a strong scientific foundation of evidence to support the safety and efficacy of the LINX procedure. Today, we are excited to announce this partnership with
An estimated 1 in 5 U.S. adults suffer from GERD, a chronic, often progressive disease that can cause debilitating symptoms and in certain cases lead to esophageal cancer. GERD is caused by a weak esophageal sphincter muscle that fails to control reflux of harmful gastric fluids from the stomach into the esophagus. Until recently, the only available treatment is a more invasive procedure which requires a portion of the patient's stomach to be dissected and wrapped around the esophagus to restore the sphincter. The LINX System is a much less invasive procedure for the patient. It allows surgeons to leave the stomach intact by using a small device to augment the sphincter; typically patients go home the same day of the procedure.
LINX is a small implant comprised of interlinked titanium beads with magnetic cores. The magnetic attraction between the beads augments the existing esophageal sphincter's barrier function to prevent reflux. The device is implanted using a standard minimally invasive laparoscopic procedure and is an alternative to the more anatomically disruptive fundoplication, commonly used in surgical anti-reflux procedures. The LINX procedure does have potential risks, and contraindications.
According to Blair Jobe, MD Program Director and
About
About
About Torax Medical
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/highmark-health-allegheny-health-network-and-torax-medical-partner-to-explore-cost-effectiveness-of-new-procedure-to-treat-gastro-esophageal-reflux-disease-gerd-300139418.html
SOURCE



Advisor News
- Health insurance premium tax bill advancing
- The Medi-Cal money pit
- The untapped potential of Qualified Longevity Annuity Contracts
- NYC's fiscal outlook on downslide over budget gaps
- Health insurance premium tax bill moving in Iowa House
More Advisor NewsAnnuity News
- An Application for the Trademark “GREAT-WEST LIFE & ANNUITY INSURANCE COMPANY” Has Been Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
- The forces shaping life and annuities in 2026
- Variable annuity sales surge as market confidence remains high, Wink finds
- New Allianz Life Annuity Offers Added Flexibility in Income Benefits
- How to elevate annuity discussions during tax season
More Annuity NewsHealth/Employee Benefits News
- Health insurance premium tax bill advancing
- Families oppose bill locking in Iowa Medicaid privatization
- The Medi-Cal money pit
- State auditor approves new school health trust with at least 150 school districts on board
- 5 KEY FACTS ABOUT MEDICAID PRESCRIPTION DRUGS
More Health/Employee Benefits NewsLife Insurance News
- Hulse, Murray
- Murray Giles Hulse
- Oaktree grabs control of Atlantic Coast Life Co. in blockbuster A-Cap deal
- AM Best Removes From Under Review With Developing Implications and Downgrades Credit Ratings of Banner Life Insurance Company and William Penn Life Insurance Company of New York
- The forces shaping life and annuities in 2026
More Life Insurance News